Procalcitonin to Distinguish Viral From Bacterial Origin of Pneumonia: No Premature Conclusion!-Reference-Cited by-同舟云学术

Procalcitonin to Distinguish Viral From Bacterial Origin of Pneumonia: No Premature Conclusion!

Published:2019-12-17 Issue:1 Volume:71 Page:246-247
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Blot Mathieu¹²,Chavanet Pascal¹,Piroth Lionel¹

Affiliation:

1. Infectious Diseases Department, François Mitterrand Teaching Hospital, Dijon, France

2. Lipides Nutrition Cancer laboratory, Institut National de la Santé Et de la Recherche Médicale, unit 1231, Faculty of Health Sciences, University of Burgundy, Dijon, France

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciz951/31552418/ciz951.pdf

Reference8 articles.

1. Procalcitonin to distinguish viral from bacterial pneumonia: a systematic review and meta-analysis [manuscript published online ahead of print 25 June 2019];Kamat;Clin Infect Dis,2019

2. The co-pathogenesis of influenza viruses with bacteria in the lung;McCullers;Nat Rev Microbiol,2014

3. Community-acquired pneumonia requiring hospitalization among U.S. adults;Jain;N Engl J Med,2015

4. Influenza infection: an update for clinicians;Blot;Rev Med Interne,2019

5. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness;Morens;J Infect Dis,2008

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes of C-reactive protein and Procalcitonin after four weeks of treatment in patients with pulmonary TB;Journal of Clinical Tuberculosis and Other Mycobacterial Diseases;2023-05

2. Combined use of a broad-panel respiratory multiplex PCR and procalcitonin to reduce duration of antibiotics exposure in patients with severe community-acquired pneumonia (MULTI-CAP): a multicentre, parallel-group, open-label, individual randomised trial conducted in French intensive care units;BMJ Open;2021-08

3. Reply to Peacock and Rafique and to Blot et al;Clinical Infectious Diseases;2019-12-17